About
Veocor pioneers cloud-based AI technologies to reduce cost and improve quality of care by diagnosing patients at risk of stroke who benefit from anticoagulation. Veocor has developed the first personalized tool to provide a quantitative assessment of the risk of cardiac thrombus formation and associated stroke. Veocor's technology analyzes standard ultrasound images to provide a quantitative measure of blood flow within the left ventricle, identifying areas of blood stasis which are most susceptible to thrombus formation.
Technologies
Route 53Amazon AWSMobile FriendlyApacheWordPress.orgGoogle Font APIYouTubeGoogle Analytics
Keywords
medical equipment manufacturingechocardiography analysiscardiovascular risk stratificationcardiology softwarecloud ai for cardiologymedical devicesblood flow visualizationcardiologyblood stasis quantificationfda clearance pathwaystandard dicom ultrasound analysiscloud platform analysisweb-based diagnostic softwareultrasound image analysispersonalized stroke preventionai diagnostic toolstandard ultrasound imagesai-powered diagnosticthrombus risk scorepersonalized medicinerisk managementleft ventricle flow mappingheart failure risk assessmentultrasound flow analysiscardiac imaging analysisoffices of physiciansthrombosis predictionstroke preventionclinical decision supportcloud-based medical technology
Company Information
- Employees0
Location
San Diego, California, United States, 92092
